Comparison of measles seroconversion rates at 13 months of age between HIV-infected children vaccinated at 12 months of age and HIV-infected children vaccinated at 6 and 12 months of age Throughout study [clinicaltrials_resource:a21121fd5bc47fbdbd5a645b4676f7bc]
Participants who receive vaccination at 6 and 12 months of age
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Comparison of measles seroconversion rates at 13 months of age between HIV-infected children vaccinated at 12 months of age and HIV-infected children vaccinated at 6 and 12 months of age Throughout study [clinicaltrials_resource:a21121fd5bc47fbdbd5a645b4676f7bc]
Participants who receive vaccination at 6 and 12 months of age
Bio2RDF identifier
a21121fd5bc47fbdbd5a645b4676f7bc
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:a21121fd5bc47fbdbd5a645b4676f7bc
measure [clinicaltrials_vocabulary:measure]
Comparison of measles seroconv ...... ated at 6 and 12 months of age
time frame [clinicaltrials_vocabulary:time-frame]
Throughout study
description
Participants who receive vaccination at 6 and 12 months of age
identifier
clinicaltrials_resource:a21121fd5bc47fbdbd5a645b4676f7bc
title
Comparison of measles seroconv ...... months of age Throughout study
@en
type
label
Comparison of measles seroconv ...... 121fd5bc47fbdbd5a645b4676f7bc]
@en